跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FABIOR tazarotene 0.1% w/w foam aerosol can - TGA Drug Approval Details
Approvals
/
TGA
/
FABIOR tazarotene 0.1% w/w foam aerosol can
Approved
STANDARD
FABIOR tazarotene 0.1% w/w foam aerosol can
Mayne Pharma International Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
dfb16cfdf41e232b
Company
Mayne Pharma International Pty Ltd
Type
Standard
Approval Details
Approval Id
dfb16cfdf41e232b
Product Name
FABIOR tazarotene 0.1% w/w foam aerosol can
Artg Id
364526
Artg Name
FABIOR tazarotene 0.1% w/w foam aerosol can
Sponsor
Mayne Pharma International Pty Ltd
Company Detail Path
/organization/mayne-pharma-international-pty-ltd
Artg Date
2022-11-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
dfb16cfdf41e232b
Type
Standard
Back to TGA Approvals
